Compositions and treatments for modulating kinase and/or HMG-CoA reductase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060111436A1
SERIAL NO

11118098

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides compositions of matter, kits and methods for their use in the treatment of kinase-related conditions and/or HMG-CoA reductase-related conditions. In particular, the invention provides compositions for treating immuno-compromised and/or cardiovascular conditions in an animal subject by modulating one or more MAP kinase(s) and/or HMG-CoA reductase, as well as providing formulations and modes of administering such compositions. The invention further provides methods for the rational design of modulators of MAP kinases, HMG-CoA reductase, or both for use in the practice of the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NUMERATE INC1150 BAYHILL DRIVE SUITE 203 SAN BRUNO CA 94066

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Griffin, John Atherton, CA 231 3639

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation